Market Research Logo

Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018

Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018 provides an overview of Ventricular Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ventricular Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ventricular Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ventricular Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ventricular Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Ventricular Assist Devices Overview
3 Products under Development
3.1 Ventricular Assist Devices - Pipeline Products by Stage of Development
3.2 Ventricular Assist Devices - Pipeline Products by Segment
3.3 Ventricular Assist Devices - Pipeline Products by Territory
3.4 Ventricular Assist Devices - Pipeline Products by Regulatory Path
3.5 Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
3.6 Ventricular Assist Devices - Ongoing Clinical Trials
4 Ventricular Assist Devices - Pipeline Products under Development by Companies
4.1 Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
4.2 Ventricular Assist Devices - Pipeline Products by Stage of Development
5 Ventricular Assist Devices Companies and Product Overview
5.1 Abiomed Inc Company Overview
5.2 BioVentrix Inc Company Overview
5.3 Braile Biomedica Ltda Company Overview
5.4 Calon Cardio-Technology Ltd Company Overview
5.5 CardiacAssist Inc Company Overview
5.6 CARDIAnove Company Overview
5.7 Carnegie Mellon University Company Overview
5.8 Cleveland Clinic Hospital Company Overview
5.9 Cleveland Heart Inc Company Overview
5.10 CorAssist Cardiovascular Ltd Company Overview
5.11 Corinnova Inc Company Overview
5.12 CorWave Company Overview
5.13 Drexel University Company Overview
5.14 DUALIS MedTech GmbH Company Overview
5.15 Duke University Company Overview
5.16 Ension, Inc. Company Overview
5.17 Evaheart Inc Company Overview
5.18 Everheart Systems, LLC Company Overview
5.19 FineHeart Company Overview
5.20 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview
5.21 Harvard University Company Overview
5.22 HeartWare International Inc Company Overview
5.23 Indiana University Company Overview
5.24 Jarvik Heart Inc Company Overview
5.25 LaunchPoint Technologies, Inc. Company Overview
5.26 Leviticus Cardio Ltd Company Overview
5.27 Levram Medical Systems Ltd Company Overview
5.28 Medtronic plc Company Overview
5.29 Michigan Critical Care Consultants, Inc. Company Overview
5.30 MyoCardioCare, Inc. Company Overview
5.31 Myotech, LLC (Inactive) Company Overview
5.32 NeoCardial Technologies, LLC Company Overview
5.33 Nipro Corp Company Overview
5.34 Novapump GmbH Company Overview
5.35 NuPulseCV Company Overview
5.36 Pennsylvania State University Company Overview
5.37 Perfusion Solution Inc Company Overview
5.38 PlugMed Heart SAS Company Overview
5.39 Procyrion Company Overview
5.40 Purdue University Company Overview
5.41 ReliantHeart, Inc. Company Overview
5.42 Rutgers The State University of New Jersey Company Overview
5.43 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.44 St. Jude Medical LLC Company Overview
5.45 Sunshine Heart Company, Pty. Ltd. Company Overview
5.46 Syncardia Systems LLC Company Overview
5.47 Teleflex Inc Company Overview
5.48 Terumo Corp Company Overview
5.49 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview
5.50 Thoratec Corp Company Overview
5.51 Tokyo Medical and Dental University Company Overview
5.52 U.S. Stem Cell Inc Company Overview
5.53 University of Louisville Company Overview
5.54 University of Michigan Company Overview
5.55 Vadovations, Inc. Company Overview
5.56 Windmill Cardiovascular Systems, Inc. Company Overview
5.57 Yale University Company Overview
6 Ventricular Assist Devices- Recent Developments
6.1 May 22, 2018: Abbott Recalls the HeartMate 3 Left Ventricular Assist System Due to Potential Malfunction that may Lead to Graft Occlusion
6.2 May 15, 2018: Micron Solutions Reports 2018 First Quarter Results
6.3 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration
6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.6 May 09, 2018: U.S. Stem Cell Reports First Quarter Results
6.7 May 04, 2018: Abbott Implements Corrective Action for HeartMate 3 Heart Pump
6.8 May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
6.9 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.10 Apr 30, 2018: Procyrion Appoints Clinical Operations Pro Tara Burt As Associate Director Of Clinical Affairs
6.11 Apr 16, 2018: USRM Reports 2017 Financial Results
6.12 Apr 10, 2018: Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study
6.13 Apr 09, 2018: Medtronic to Unveil Additional Clinical Data on HVAD System at ISHLT 2018
6.14 Apr 04, 2018: Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg
6.15 Apr 02, 2018: Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor
6.16 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
6.17 Mar 26, 2018: Micron Solutions Reports 2017 Fourth Quarter and Year End Results
6.18 Mar 21, 2018: Procyrion Names Elisabeth Neely Senior Vice President Of Clinical And Regulatory Affairs, Formerly With Abbott
6.19 Mar 14, 2018: Baylor College of Medicine approved for $489,000 in funding for LVAD treatment decision support
6.20 Mar 13, 2018: UR Medicine Leads U.S. in Minimally Invasive Surgery for Newest LVAD Heart Pump
6.21 Mar 11, 2018: New Long-term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's Heartmate 3 Heart Pump
6.22 Mar 01, 2018: Palmetto Health is first facility in state to implant HeartMate 3 LVAD outside of research trials
6.23 Feb 26, 2018: Successful Outcomes Seen in First-in-Human Trial of NuPulseCV''s Intravascular Ventricular Assist System (iVAS)
6.24 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
6.25 Feb 14, 2018: Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures
6.26 Feb 13, 2018: Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
6.27 Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery
6.28 Feb 13, 2018: Carmat: 2017 Annual Results
6.29 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.30 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
6.31 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
6.32 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.33 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year
6.34 Jan 04, 2018: Apollo Hospitals, Hyderguda successfully implanted the LVAD Heart Mate 3 to give a new lease of life for a 70-year-old heart failure patient.
6.35 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 2: Ventricular Assist Devices - Pipeline Products by Segment
Table 3: Ventricular Assist Devices - Pipeline Products by Territory
Table 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path
Table 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Table 6: Ventricular Assist Devices - Ongoing Clinical Trials
Table 7: Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
Table 8: Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 9: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Impella BTR - Product Status
Table 11: Impella BTR - Product Description
Table 12: Impella CP (Cardiac Power) - Product Status
Table 13: Impella CP (Cardiac Power) - Product Description
Table 14: Impella ECP - Product Status
Table 15: Impella ECP - Product Description
Table 16: Impella RP - Product Status
Table 17: Impella RP - Product Description
Table 18: Next Generation Impella CP - STEMI - Product Status
Table 19: Next Generation Impella CP - STEMI - Product Description
Table 20: Abiomed Inc - Ongoing Clinical Trials Overview
Table 21: Impella RP - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry
Table 22: Impella CP (Cardiac Power) - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry
Table 23: Impella CP (Cardiac Power) - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
Table 24: Impella CP (Cardiac Power) - Pulsecath mechanicaL Support Evaluation (PULSE) - Trial
Table 25: Next Generation Impella CP - STEMI - Door to Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study
Table 26: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: PliCath HF - Product Status
Table 28: PliCath HF - Product Description
Table 29: BioVentrix Inc - Ongoing Clinical Trials Overview
Table 30: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy
Table 31: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Blood Pump - Product Status
Table 33: Blood Pump - Product Description
Table 34: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Calon MiniVAD - Product Status
Table 36: Calon MiniVAD - Product Description
Table 37: CathVAD - Product Status
Table 38: CathVAD - Product Description
Table 39: MicroVAD - Product Status
Table 40: MicroVAD - Product Description
Table 41: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Pediatric pVAD - Product Status
Table 43: Pediatric pVAD - Product Description
Table 44: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview
Table 45: CARDIAnove Pump - Product Status
Table 46: CARDIAnove Pump - Product Description
Table 47: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
Table 48: tVAD - Heart Failure - Product Status
Table 49: tVAD - Heart Failure - Product Description
Table 50: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 51: PediPump - Product Status
Table 52: PediPump - Product Description
Table 53: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: SmartHeart LVAD - Product Status
Table 55: SmartHeart LVAD - Product Description
Table 56: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 57: CORolla - Product Status
Table 58: CORolla - Product Description
Table 59: ImCardia - Product Status
Table 60: ImCardia - Product Description
Table 61: CorAssist Cardiovascular Ltd - Ongoing Clinical Trials Overview
Table 62: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction
Table 63: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility
Table 64: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 65: CardiacSTAR - Bridge To Decision - Product Status
Table 66: CardiacSTAR - Bridge To Decision - Product Description
Table 67: CardiacSTAR - Bridge To Recovery - Product Status
Table 68: CardiacSTAR - Bridge To Recovery - Product Description
Table 69: CardiacSTAR - Bridge To Transplant - Product Status
Table 70: CardiacSTAR - Bridge To Transplant - Product Description
Table 71: CardiacSTAR - Destination Therapy - Product Status
Table 72: CardiacSTAR - Destination Therapy - Product Description
Table 73: CardiacSTAR - Heart Rehabilitation - Product Status
Table 74: CardiacSTAR - Heart Rehabilitation - Product Description
Table 75: EpicHeart - Soft Robotic Heart Device - Product Status
Table 76: EpicHeart - Soft Robotic Heart Device - Product Description
Table 77: CorWave Pipeline Products & Ongoing Clinical Trials Overview
Table 78: CorWave Neptune - Product Status
Table 79: CorWave Neptune - Product Description
Table 80: CorWave Nemo - Product Status
Table 81: CorWave Nemo - Product Description
Table 82: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Intravascular Blood Pump - Product Status
Table 84: Intravascular Blood Pump - Product Description
Table 85: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 86: CAREFLOW Pump - Product Status
Table 87: CAREFLOW Pump - Product Description
Table 88: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Para-Aortic Blood Pump - Product Status
Table 90: Para-Aortic Blood Pump - Product Description
Table 91: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 92: CardioFlowPQ - Product Status
Table 93: CardioFlowPQ - Product Description
Table 94: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 95: EVAHEART Left Ventricular Assist System - Product Status
Table 96: EVAHEART Left Ventricular Assist System - Product Description
Table 97: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Fully Implantable Left Ventricular Assist Device - Product Status
Table 99: Fully Implantable Left Ventricular Assist Device - Product Description
Table 100: FineHeart Pipeline Products & Ongoing Clinical Trials Overview
Table 101: ICOMS - Product Status
Table 102: ICOMS - Product Description
Table 103: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview
Table 104: Ventricular Assist Device - Product Status
Table 105: Ventricular Assist Device - Product Description
Table 106: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Soft Robotic Sleeve - Product Status
Table 108: Soft Robotic Sleeve - Product Description
Table 109: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 110: BiVAD - Product Status
Table 111: BiVAD - Product Description
Table 112: Fully Implantable VAD System - Product Status
Table 113: Fully Implantable VAD System - Product Description
Table 114: HeartWare IV-VAD - Product Status
Table 115: HeartWare IV-VAD - Product Description
Table 116: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Status
Table 117: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Description
Table 118: Levacor Rotary VAD - Product Status
Table 119: Levacor Rotary VAD - Product Description
Table 120: Longhorn - Product Status
Table 121: Longhorn - Product Description
Table 122: MiFlow VAD - Product Status
Table 123: MiFlow VAD - Product Description
Table 124: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Status
Table 125: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Description
Table 126: VCAN Trans-Mitral - Product Status
Table 127: VCAN Trans-Mitral - Product Description
Table 128: HeartWare International Inc - Ongoing Clinical Trials Overview
Table 129: Miniaturized Ventricular Assist Device (MVAD) Pump - Multi Center, Prospective, Non-randomized, Single-arm Trial Evaluating the Clinical Safety and Performance of the HeartWare MVAD System for the Treatment of Advanced Heart Failure
Table 130: Indiana University Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Bi-Conical Heart Pump - Product Status
Table 132: Bi-Conical Heart Pump - Product Description
Table 133: Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Jarvik 15mm LVAD System - Product Status
Table 135: Jarvik 15mm LVAD System - Product Description
Table 136: Jarvik 2000 Heart - Bridge To Transplant - Product Status
Table 137: Jarvik 2000 Heart - Bridge To Transplant - Product Description
Table 138: Jarvik 2000 Heart - Destination Therapy - Product Status
Table 139: Jarvik 2000 Heart - Destination Therapy - Product Description
Table 140: Jarvik Heart Inc - Ongoing Clinical Trials Overview
Table 141: Jarvik 2000 Heart - Destination Therapy - Evaluation of the Jarvik 2000 Left Ventricular Assist System with Post-auricular Connector--Destination Therapy Study
Table 142: LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Pediaflow Pediatric VAD - Product Status
Table 144: Pediaflow Pediatric VAD - Product Description
Table 145: Streamliner VAD - Product Status
Table 146: Streamliner VAD - Product Description
Table 147: Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Coplanar Energy Transfer System - Product Status
Table 149: Coplanar Energy Transfer System - Product Description
Table 150: Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 151: LEVRAM-Ventricular Assist Device - Product Status
Table 152: LEVRAM-Ventricular Assist Device - Product Description
Table 153: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 154: HVAD System - Thoracotomy - Product Status
1.2 List of Figures
Figure 1: Ventricular Assist Devices - Pipeline Products by Stage of Development
Figure 2: Ventricular Assist Devices - Pipeline Products by Segment
Figure 3: Ventricular Assist Devices - Pipeline Products by Territory
Figure 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path
Figure 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Figure 6: Ventricular Assist Devices - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report